In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...
In a bid to bring down the cost of insulin, California under Gov. Gavin Newsom inked a contract to produce the drug. It's ...
meaning it can be substituted at the pharmacy for Lantus, the brand name insulin glargine, without needing a separate prescription. The length of time it takes for a company to develop a drug, get ...
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...